Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066701 · ClinicalTrials.gov registry record
Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 250
- Enrollment target
NCT02066701: Completed study, sponsored by Mayo Clinic.
NCT02066701 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02066701 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
This study is to identify potential markers from esophageal biopsies and brush cytology for feasibility of use in stool specimens for detection of Barretts Esophagus.
Primary Outcome
we will plan to identify the best markers from highly selected marker candidates to differentiate between subjects who have BE and those who do not have BE.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-12 |
What the finished NCT02066701 record still lists
NCT02066701 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02066701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02066701 about?
NCT02066701 is a clinical study titled "Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers". This study is to identify potential markers from esophageal biopsies and brush cytology for feasibility of use in stool specimens for detection of Barretts Esophagus.
What is the current status of trial NCT02066701?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2012-05. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT02066701?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia